Skip to main content
logo
Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.6070
-0.0337 (-5.26%)
Oct 7, 2025, 2:16 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Novel Therapeutics
536.36K
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
19.29%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
United States
536.36K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
19.29%
Log In
Log In
Log In
Log In
Upgrade